OP0169 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase 3, Randomized, Controlled Trials

Dafna D. Gladman, Arthur Kavanaugh, Ade Adebajo, Juan J. Gómez‐Reino, J. Wollenhaupt, Maurizio Cutolo, Georg Schett, Éric Lespessailles, M. McIlraith, C. Hu,

Annals of the Rheumatic Diseases · 2015 · 16 citations · 0 references

Concepts